Okyo Pharma Ltd. (OKYO)
NASDAQ · Healthcare
Okyo Pharma Ltd. EBITDA 2020–2025
Okyo Pharma Ltd. annual/quarterly ebitda history and growth rate from 2020 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Okyo Pharma Ltd. annual ebitda for 2025 was -7.1 M, a 54.93% decrease from 2024.
- Okyo Pharma Ltd. annual ebitda for 2024 was -15.7 M, a 19.44% increase from 2023.
- Okyo Pharma Ltd. annual ebitda for 2023 was -13.2 M, a 184.71% increase from 2022.
- Okyo Pharma Ltd. annual ebitda for 2022 was -4.6 M.
No data available.
Okyo Pharma Ltd. EBITDA — FAQ
Okyo Pharma Ltd. (OKYO) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OKYO's ebitda history?
The chart and table above show Okyo Pharma Ltd.'s ebitda by year and by quarter, including the growth rate.